Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Sarcoma 2Glioblastoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Glioma 1Desmoid Tumors 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Irinotecan 3Temozolomide 2Doxorubicin 2Cyclophosphamide 2robatumumab 1palbociclib 1liposomal doxorubicin 1cc-486 1Vincristine 1Topotecan 1Taxes 1Surveys and Questionnaires 1Quality of Life 1Psychology, Positive 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1Gemcitabine 1Etoposide 1Drug Therapy 1Cyproheptadine 1Carboplatin 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × liposomal doxorubicin × CNS × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡